NasdaqCM - Delayed Quote USD
Cyclacel Pharmaceuticals, Inc. (CYCC)
0.4121
+0.0531
+(14.79%)
At close: June 13 at 4:00:02 PM EDT
0.3953
-0.02
(-4.08%)
After hours: June 13 at 7:51:11 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 196,016,980 | 32 |
| Sales | 194,628,832 | 2 |
| Net Shares Purchased (Sold) | 1,388,148 | 34 |
| Total Insider Shares Held | 13.7M | -- |
| % Net Shares Purchased (Sold) | 11.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LAZAR DAVID ELLIOT Chief Executive Officer | Sale at price 0.03 per share. | Direct | 5,507,996 | Feb 26, 2025 |
| LAZAR DAVID ELLIOT Chief Executive Officer | -- | Direct | -- | Feb 26, 2025 |
| NATAN DAVID Director | -- | Direct | -- | Jan 2, 2025 |
| SCHWARTZ BRIAN Officer and Director | -- | Direct | -- | Jan 29, 2024 |
| ROMBOTIS SPIRO GEORGE Chief Executive Officer | Purchase at price 3.32 per share. | Direct | 20,122 | Dec 21, 2023 |
| MCBARRON PAUL Chief Operating Officer | Purchase at price 3.32 per share. | Direct | 6,252 | Dec 21, 2023 |
| BARKER SAMUEL L Director | -- | Direct | -- | Jun 30, 2023 |
| HENNEY CHRISTOPHER S Director | -- | Direct | -- | Jun 30, 2023 |
| WALKER KARIN LORRAINE Director | -- | Direct | -- | Jun 30, 2023 |
| SCHWARTZ BRIAN Director | -- | Direct | -- | Jun 30, 2023 |
| SPIEGEL ROBERT J Director | -- | Direct | -- | Jun 30, 2023 |
| FERGUSON KENNETH M Director | -- | Direct | -- | Jun 30, 2023 |
Related Tickers
ABP Abpro Corporation
0.2150
-11.85%
TNFA TNF Pharmaceuticals, Inc.
0.1370
-10.57%
EQ Equillium, Inc.
0.3470
-10.22%
ONCO Onconetix, Inc.
4.7300
-24.90%
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%
ADIL Adial Pharmaceuticals, Inc.
0.3501
-21.94%
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
INTS Intensity Therapeutics, Inc.
0.3180
-0.63%
PALI Palisade Bio, Inc.
0.6401
-7.23%
CLRB Cellectar Biosciences, Inc.
0.4132
-5.45%